Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. (AKBA) is a publicly traded company in the Unknown sector. Across all available filings, 34 corporate insiders have executed 311 transactions totaling $31.4M, demonstrating a bullish sentiment with $24.4M in net insider flow. The most recent transaction on Jun 30, 2025 involved a sale of 41,314 shares valued at $151.6K.
AKBA Insider Activity Summary
Who Is Buying AKBA Stock?
No significant insider buying has been recorded for AKBA in the recent period.
Who Is Selling AKBA Stock?
No significant insider selling has been recorded for AKBA in the recent period.
Is Akebia Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AKBA is bullish with an Insider Alignment Score of 89/100 and a net flow of $24.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AKBA Frequently Asked Questions
Understanding AKBA Insider Activity
Insider trading at Akebia Therapeutics, Inc. (AKBA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 34 insiders are actively trading AKBA stock, having executed 311 transactions in the past 90 days. The most active insider is Muneer A. Satter (Executive), who has made 15 transactions totaling $20.7M.
Related Tools
Track Akebia Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AKBA file new Form 4 transactions